動物神経変性疾患診断市場、市場規模、シェア、動向、産業分析レポート：製品別、検査別、動物タイプ別、適応症別、最終用途別、地域別、2025年～2034年の市場予測

Polaris Market Research社の最新調査によると、動物神経変性疾患診断の市場規模は2034年までに8億579万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

動物神経変性疾患診断は、広範な動物用ヘルスケア産業の中でも、動物の神経変性疾患の検出と管理に焦点を当てた専門分野です。イヌの認知機能障害症候群（CDS）、ネコの認知症、ウマの運動ニューロン疾患などの神経変性疾患は、高齢化するペットや家畜における深刻な健康問題として認識されるようになってきています。早期かつ正確な診断は、これらの疾患を管理し、動物福祉を改善し、生活の質を向上させる上で極めて重要です。

この市場には、高度な画像診断技術、脳脊髄液（CSF）分析、遺伝子治療、バイオマーカー評価など、さまざまな診断ツールが含まれています。動物の神経疾患に対する認識の高まりと獣医診断学の進歩が相まって、市場拡大の原動力となっています。さらに、ペットを家族の一員と見なす「ペットの人間化」の動向の高まりは、高度な獣医療への支出の増加につながり、神経変性疾患診断薬の需要をさらに押し上げています。

動物神経変性疾患診断市場レポートハイライト

製品別では、動物の神経疾患の早期発見と正確な診断に不可欠な役割を果たす消耗品・試薬・キット分野が2024年に大きなシェアを占めました。

検査別では、動物の脳や脊髄の異常を特定する上で重要な役割を果たすイメージングセグメントが2024年の市場シェアを独占しました。

動物タイプ別では、高齢化したペット、特に犬や猫における神経疾患の有病率が上昇していることから、コンパニオンセグメントが2024年に最大のシェアを占めました。

北米の動物用神経変性疾患診断市場は、ペット、特に犬と猫の集団における神経変性疾患の有病率の上昇により、2024年に最大のシェアを占めました。

欧州の市場は、ペットの老年人口の増加と神経疾患に対する意識の高まりにより、今後数年間で堅調なペースで成長すると予測されています。

アジア太平洋市場は、ペット飼育の増加、可処分所得の増加、獣医ヘルスケアインフラの改善により、2034年にはかなりのシェアを占めると予測されています。

世界の主な市場プレイヤーには、ACUVET BIOTECH、Antech Diagnostics, Inc.、Avacta Animal Health Limited、Heska Corporation、IDEXX Laboratories, Inc.、Life Diagnostics、Merck &Co.

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の動物神経変性疾患診断市場の洞察

• 適応スナップショット
• 動物神経変性疾患診断市場力学
  • 促進要因と機会
    • 世界中で可処分所得が増加
    • 獣医神経学における技術的進歩
  • 抑制要因と課題
    • 普遍的に受け入れられている診断検査の欠如
• PESTEL分析
• 動物神経変性疾患診断市場の動向
• バリューチェーン分析

第5章 世界の動物神経変性疾患診断市場：製品別

• 主な調査結果
• イントロダクション
• 消耗品、試薬、キット
• 機器と器具

第6章 世界の動物神経変性疾患診断市場：検査別

• 主な調査結果
• イントロダクション
• 画像診断
• バイオマーカー診断検査
• その他

第7章 世界の動物神経変性疾患診断市場：動物タイプ別

• 主な調査結果
• イントロダクション
• 家畜
• 仲間

第8章 世界の動物神経変性疾患診断市場：適応症別

• 主な調査結果
• イントロダクション
• 認知機能障害
• 小脳アビオトロフィー
• 海綿状脳症
• その他

第9章 世界の動物神経変性疾患診断市場：最終用途別

• 主な調査結果
• イントロダクション
• 動物病院と診療所
• 獣医診断研究所
• その他

第10章 世界の動物神経変性疾患診断市場：地域別

• 主な調査結果
• イントロダクション
  • 動物神経変性疾患診断市場評価：地域別、2020～2034年
• 北米
  • 北米：製品別、2020～2034年
  • 北米：検査別、2020～2034年
  • 北米：動物タイプ別、2020～2034年
  • 北米：適応症別、2020～2034年
  • 北米：最終用途別、2020～2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：製品別、2020～2034年
  • 欧州：検査別、2020～2034年
  • 欧州：動物タイプ別、2020～2034年
  • 欧州：適応症別、2020～2034年
  • 欧州：最終用途別、2020～2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋
  • アジア太平洋地域：製品別、2020～2034年
  • アジア太平洋地域：検査別、2020～2034年
  • アジア太平洋地域：動物タイプ別、2020～2034年
  • アジア太平洋地域：適応症別、2020～2034年
  • アジア太平洋地域：最終用途別、2020～2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ
  • 中東・アフリカ：製品別、2020～2034年
  • 中東・アフリカ：検査別、2020～2034年
  • 中東・アフリカ：動物タイプ別、2020～2034年
  • 中東・アフリカ：適応症別、2020～2034年
  • 中東・アフリカ：最終用途別、2020～2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東とアフリカ
• ラテンアメリカ
  • ラテンアメリカ：製品別、2020～2034年
  • ラテンアメリカ：検査別、2020～2034年
  • ラテンアメリカ：動物タイプ別、2020-2034年
  • ラテンアメリカ：適応症別、2020～2034年
  • ラテンアメリカ：最終用途別、2020～2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第11章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第12章 企業プロファイル

• ACUVET BIOTECH
• Antech Diagnostics, Inc.
• Avacta Animal Health Limited
• Heska Corporation
• IDEXX Laboratories, Inc.
• Life Diagnostics

List of Tables:

• Table 1 Global Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 2 Global Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 3 Global Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 4 Global Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 5 Global Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 6 North America: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 7 North America: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 8 North America: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 9 North America: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 10 North America: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 11 U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 12 U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 13 U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 14 U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 15 U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 16 Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 17 Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 18 Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 19 Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 20 Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 21 Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 22 Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 23 Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 24 Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 25 Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 26 UK: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 27 UK: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 28 UK: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 29 UK: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 30 UK: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 31 France: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 32 France: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 33 France: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 34 France: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 35 France: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 36 Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 37 Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 38 Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 39 Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 40 Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 41 Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 42 Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 43 Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 44 Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 45 Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 46 Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 47 Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 48 Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 49 Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 50 Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 51 Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 52 Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 53 Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 54 Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 55 Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 56 Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 57 Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 58 Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 59 Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 60 Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 61 Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 62 Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 63 Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 64 Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 65 Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 66 Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 67 Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 68 Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 69 Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 70 Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 71 China: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 72 China: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 73 China: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 74 China: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 75 China: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 76 India: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 77 India: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 78 India: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 79 India: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 80 India: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 81 Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 82 Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 83 Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 84 Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 85 Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 86 Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 87 Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 88 Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 89 Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 90 Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 91 Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 92 Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 93 Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 94 Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 95 Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 96 South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 97 South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 98 South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 99 South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 100 South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 101 Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 102 Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 103 Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 104 Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 105 Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 106 Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 107 Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 108 Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 109 Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 110 Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 111 Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 112 Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 113 Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 114 Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 115 Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 116 Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 117 Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 118 Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 119 Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 120 Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 121 UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 122 UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 123 UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 124 UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 125 UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 126 Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 127 Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 128 Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 129 Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 130 Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 131 South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 132 South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 133 South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 134 South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 135 South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 136 Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 137 Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 138 Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 139 Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 140 Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 141 Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 142 Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 143 Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 144 Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 145 Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 146 Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 147 Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 148 Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 149 Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 150 Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 151 Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 152 Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 153 Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 154 Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 155 Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 156 Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 157 Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 158 Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 159 Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 160 Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• Table 161 Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• Table 162 Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• Table 163 Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• Table 164 Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• Table 165 Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)

List of Figures:

• Figure 1. Global Veterinary Neurodegenerative Disease Diagnostics Market, 2020-2034 (USD Million)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Product
• Figure 7. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2024 & 2034 (USD Million)
• Figure 8. Market by Test
• Figure 9. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2024 & 2034 (USD Million)
• Figure 10. Market by Animal Type
• Figure 11. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2024 & 2034 (USD Million)
• Figure 12. Market by Indication
• Figure 13. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2024 & 2034 (USD Million)
• Figure 14. Market by End Use
• Figure 15. Global Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2024 & 2034 (USD Million)

The veterinary neurodegenerative disease diagnostics market size is expected to reach USD 805.79 million by 2034, according to a new study by Polaris Market Research. The report "Veterinary Neurodegenerative Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report By Product (Consumables, Reagents & Kits and Equipment & Instruments), By Test, By Animal Type, By Indication, By End Use, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The veterinary neurodegenerative disease diagnostics is a specialized sector within the broader veterinary healthcare industry, focusing on the detection and management of neurodegenerative disorders in animals. Neurodegenerative diseases such as cognitive dysfunction syndrome (CDS) in dogs, feline dementia, and equine motor neuron disease are increasingly recognized as serious health concerns in aging pets and livestock. Early and accurate diagnosis is crucial for managing these conditions, improving animal welfare, and extending quality of life.

The market encompasses various diagnostic tools, including advanced imaging techniques, cerebrospinal fluid (CSF) analysis, gene therapy, and biomarker assessments. The growing awareness of neurological disorders in animals, coupled with advancements in veterinary diagnostics, is driving market expansion. Additionally, the rising trend of pet humanization, where pets are considered family members, is leading to increased spending on advanced veterinary care, further propelling demand for neurodegenerative disease diagnostics.

Veterinary Neurodegenerative Disease Diagnostics Market Report Highlights

In terms of product, the consumables, reagents & kits segment accounted for a major share in 2024 due to their essential role in early detection and accurate diagnosis of neurological disorders in animals.

Based on test, the imaging segment dominated the market share in 2024 due to its critical role in identifying abnormalities in the brain and spinal cord of animals.

In terms of animal type, the companion segment held the largest share in 2024, owing to the rising prevalence of neurological disorders in aging pets, particularly dogs and cats.

The North America veterinary neurodegenerative disease diagnostics market accounted for the largest share in 2024 due to the rising prevalence of neurodegenerative disorders in pets, particularly in dog and cat populations.

The market in Europe is projected to grow at a robust pace in the coming years, owing to the increasing geriatric pet population and growing awareness of neurological disorders.

The market in Asia Pacific is projected to hold a substantial share in 2034 due to rising pet adoption, increasing disposable income, and improving veterinary healthcare infrastructure.

A few global key market players include ACUVET BIOTECH; Antech Diagnostics, Inc.; Avacta Animal Health Limited; Heska Corporation; IDEXX Laboratories, Inc.; Life Diagnostics; Merck & Co., Inc.; Mercodia AB; MI:RNA Diagnostics Ltd.; Virbac; and Zoetis.

Polaris Market Research has segmented the veterinary neurodegenerative disease diagnostics market report on the basis of product, test, animal type, indication, end use, and region:

By Product Outlook (Revenue, USD Million, 2020-2034)

Consumables, Reagents & Kits

Equipment & Instruments

By Test Outlook (Revenue, USD Million, 2020-2034)

Imaging

MRI (Magnetic Resonance Imaging)

CT (Computed Tomography)

Others

Biomarker Diagnostic Tests

CSF (Cerebrospinal Fluid) biomarkers

Blood-based biomarkers

Others

Others

By Animal Type Outlook (Revenue, USD Million, 2020-2034)

Livestock

Sheep

Cattle

Others

Companion

Canine

Feline

Equine

Others

By Indication Outlook (Revenue, USD Million, 2020-2034)

Cognitive Dysfunction

Cerebellar Abiotrophy

Spongiform Encephalopathies

Others

By End Use Outlook (Revenue, USD Million, 2020-2034

Veterinary Hospitals and Clinics

Veterinary Diagnostic Laboratories

Others

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Veterinary Neurodegenerative Disease Diagnostics Market Insights

• 4.1. Veterinary Neurodegenerative Disease Diagnostics Market - Indication Snapshot
• 4.2. Veterinary Neurodegenerative Disease Diagnostics Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increasing Disposable Income Worldwide
    • 4.2.1.2. Technological Advancements in Veterinary Neurology
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Lack of a universally accepted diagnostic test
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Veterinary Neurodegenerative Disease Diagnostics Market Trends
• 4.6. Value Chain Analysis

5. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Product

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
• 5.3. Consumables, Reagents & Kits
  • 5.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Consumables, Reagents & Kits, by Region, 2020-2034 (USD Million)
• 5.4. Equipment & Instruments
  • 5.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Equipment & Instruments, by Region, 2020-2034 (USD Million)

6. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Test

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
• 6.3. Imaging
  • 6.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Imaging, by Region, 2020-2034 (USD Million)
  • 6.3.2. MRI (Magnetic Resonance Imaging)
    • 6.3.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by MRI (Magnetic Resonance Imaging), by Region, 2020-2034 (USD Million)
  • 6.3.3. CT (Computed Tomography)
    • 6.3.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by CT (Computed Tomography), by Region, 2020-2034 (USD Million)
  • 6.3.4. Others
    • 6.3.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)
• 6.4. Biomarker Diagnostic Test
  • 6.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Biomarker Diagnostic Test, by Region, 2020-2034 (USD Million)
  • 6.4.2. CSF (Cerebrospinal Fluid) biomarkers
    • 6.4.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by CSF (Cerebrospinal Fluid) biomarkers, by Region, 2020-2034 (USD Million)
  • 6.4.3. Blood-based biomarkers
    • 6.4.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Blood-based biomarkers, by Region, 2020-2034 (USD Million)
  • 6.4.4. Others
    • 6.4.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)
• 6.5. Others
  • 6.5.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
• 7.3. Livestock
  • 7.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Livestock, by Region, 2020-2034 (USD Million)
  • 7.3.2. Sheep
    • 7.3.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Sheep, by Region, 2020-2034 (USD Million)
  • 7.3.3. Cattle
    • 7.3.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Cattle, by Region, 2020-2034 (USD Million)
  • 7.3.4. Others
    • 7.3.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Others, by Region, 2020-2034 (USD Million)
• 7.4. Companion
  • 7.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Companion, by Region, 2020-2034 (USD Million)
  • 7.4.2. Canine
    • 7.4.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Canine, by Region, 2020-2034 (USD Million)
  • 7.4.3. Feline
    • 7.4.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Feline, by Region, 2020-2034 (USD Million)
  • 7.4.4. Equine
    • 7.4.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Equine, by Region, 2020-2034 (USD Million)
  • 7.4.5. Others
    • 7.4.5.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Others, by Region, 2020-2034 (USD Million)

8. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Indication

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
• 8.3. Cognitive Dysfunction
  • 8.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Cognitive Dysfunction, by Region, 2020-2034 (USD Million)
• 8.4. Cerebellar Abiotrophy
  • 8.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Cerebellar Abiotrophy, by Region, 2020-2034 (USD Million)
• 8.5. Spongiform Encephalopathies
  • 8.5.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Spongiform Encephalopathies, by Region, 2020-2034 (USD Million)
• 8.6. Others
  • 8.6.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)

9. Global Veterinary Neurodegenerative Disease Diagnostics Market, by End Use

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• 9.3. Veterinary Hospitals and Clinics
  • 9.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Veterinary Hospitals and Clinics, by Region, 2020-2034 (USD Million)
• 9.4. Veterinary Diagnostic Laboratories
  • 9.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Veterinary Diagnostic Laboratories, by Region, 2020-2034 (USD Million)
• 9.5. Others
  • 9.5.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)

10. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Geography

• 10.1. Key Findings
• 10.2. Introduction
  • 10.2.1. Veterinary Neurodegenerative Disease Diagnostics Market Assessment, By Geography, 2020-2034 (USD Million)
• 10.3. Veterinary Neurodegenerative Disease Diagnostics Market - North America
  • 10.3.1. North America: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • 10.3.2. North America: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • 10.3.3. North America: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • 10.3.4. North America: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • 10.3.5. North America: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.3.7. Veterinary Neurodegenerative Disease Diagnostics Market - U.S.
    • 10.3.7.1. U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.3.7.2. U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.3.7.3. U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.3.7.4. U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.3.7.5. U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.3.8. Veterinary Neurodegenerative Disease Diagnostics Market - Canada
    • 10.3.8.1. Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.3.8.2. Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.3.8.3. Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.3.8.4. Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.3.8.5. Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• 10.4. Veterinary Neurodegenerative Disease Diagnostics Market - Europe
  • 10.4.1. Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • 10.4.2. Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • 10.4.3. Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • 10.4.4. Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • 10.4.5. Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.4.6. Veterinary Neurodegenerative Disease Diagnostics Market - UK
    • 10.4.6.1. UK: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.4.6.2. UK: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.4.6.3. UK: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.4.6.4. UK: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.4.6.5. UK: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.4.7. Veterinary Neurodegenerative Disease Diagnostics Market - France
    • 10.4.7.1. France: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.4.7.2. France: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.4.7.3. France: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.4.7.4. France: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.4.7.5. France: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.4.8. Veterinary Neurodegenerative Disease Diagnostics Market - Germany
    • 10.4.8.1. Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.4.8.2. Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.4.8.3. Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.4.8.4. Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.4.8.5. Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.4.9. Veterinary Neurodegenerative Disease Diagnostics Market - Italy
    • 10.4.9.1. Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.4.9.2. Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.4.9.3. Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.4.9.4. Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.4.9.5. Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.4.10. Veterinary Neurodegenerative Disease Diagnostics Market - Spain
    • 10.4.10.1. Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.4.10.2. Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.4.10.3. Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.4.10.4. Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.4.10.5. Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.4.11. Veterinary Neurodegenerative Disease Diagnostics Market - Netherlands
    • 10.4.11.1. Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.4.11.2. Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.4.11.3. Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.4.11.4. Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.4.11.5. Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.4.12. Veterinary Neurodegenerative Disease Diagnostics Market - Russia
    • 10.4.12.1. Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.4.12.2. Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.4.12.3. Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.4.12.4. Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.4.12.5. Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.4.13. Veterinary Neurodegenerative Disease Diagnostics Market - Rest of Europe
    • 10.4.13.1. Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.4.13.2. Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.4.13.3. Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.4.13.4. Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.4.13.5. Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• 10.5. Veterinary Neurodegenerative Disease Diagnostics Market - Asia Pacific
  • 10.5.1. Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • 10.5.2. Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • 10.5.3. Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • 10.5.4. Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • 10.5.5. Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.5.6. Veterinary Neurodegenerative Disease Diagnostics Market - China
    • 10.5.6.1. China: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.5.6.2. China: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.5.6.3. China: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.5.6.4. China: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.5.6.5. China: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.5.7. Veterinary Neurodegenerative Disease Diagnostics Market - India
    • 10.5.7.1. India: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.5.7.2. India: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.5.7.3. India: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.5.7.4. India: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.5.7.5. India: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.5.8. Veterinary Neurodegenerative Disease Diagnostics Market - Malaysia
    • 10.5.8.1. Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.5.8.2. Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.5.8.3. Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.5.8.4. Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.5.8.5. Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.5.9. Veterinary Neurodegenerative Disease Diagnostics Market - Japan
    • 10.5.9.1. Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.5.9.2. Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.5.9.3. Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.5.9.4. Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.5.9.5. Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.5.10. Veterinary Neurodegenerative Disease Diagnostics Market - Indonesia
    • 10.5.10.1. Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.5.10.2. Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.5.10.3. Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.5.10.4. Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.5.10.5. Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.5.11. Veterinary Neurodegenerative Disease Diagnostics Market - South Korea
    • 10.5.11.1. South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.5.11.2. South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.5.11.3. South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.5.11.4. South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.5.11.5. South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.5.12. Veterinary Neurodegenerative Disease Diagnostics Market - Australia
    • 10.5.12.1. Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.5.12.2. Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.5.12.3. Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.5.12.4. Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.5.12.5. Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.5.13. Veterinary Neurodegenerative Disease Diagnostics Market - Rest of Asia Pacific
    • 10.5.13.1. Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.5.13.2. Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.5.13.3. Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.5.13.4. Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.5.13.5. Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• 10.6. Veterinary Neurodegenerative Disease Diagnostics Market - Middle East & Africa
  • 10.6.1. Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • 10.6.2. Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • 10.6.3. Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • 10.6.4. Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • 10.6.5. Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.6.6. Veterinary Neurodegenerative Disease Diagnostics Market - Saudi Arabia
    • 10.6.6.1. Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.6.6.2. Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.6.6.3. Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.6.6.4. Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.6.6.5. Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.6.7. Veterinary Neurodegenerative Disease Diagnostics Market - UAE
    • 10.6.7.1. UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.6.7.2. UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.6.7.3. UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.6.7.4. UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.6.7.5. UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.6.8. Veterinary Neurodegenerative Disease Diagnostics Market - Israel
    • 10.6.8.1. Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.6.8.2. Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.6.8.3. Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.6.8.4. Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.6.8.5. Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.6.9. Veterinary Neurodegenerative Disease Diagnostics Market - South Africa
    • 10.6.9.1. South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.6.9.2. South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.6.9.3. South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.6.9.4. South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.6.9.5. South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.6.10. Veterinary Neurodegenerative Disease Diagnostics Market - Rest of Middle East & Africa
    • 10.6.10.1. Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.6.10.2. Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.6.10.3. Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.6.10.4. Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.6.10.5. Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
• 10.7. Veterinary Neurodegenerative Disease Diagnostics Market - Latin America
  • 10.7.1. Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • 10.7.2. Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • 10.7.3. Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • 10.7.4. Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • 10.7.5. Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.7.6. Veterinary Neurodegenerative Disease Diagnostics Market - Mexico
    • 10.7.6.1. Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.7.6.2. Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.7.6.3. Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.7.6.4. Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.7.6.5. Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.7.7. Veterinary Neurodegenerative Disease Diagnostics Market - Brazil
    • 10.7.7.1. Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.7.7.2. Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.7.7.3. Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.7.7.4. Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.7.7.5. Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.7.8. Veterinary Neurodegenerative Disease Diagnostics Market - Argentina
    • 10.7.8.1. Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.7.8.2. Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.7.8.3. Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.7.8.4. Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.7.8.5. Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.7.9. Veterinary Neurodegenerative Disease Diagnostics Market - Rest of Latin America
    • 10.7.9.1. Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.7.9.2. Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.7.9.3. Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.7.9.4. Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.7.9.5. Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)

11. Competitive Landscape

• 11.1. Expansion and Acquisition Analysis
  • 11.1.1. Expansion
  • 11.1.2. Acquisitions
• 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

• 12.1. ACUVET BIOTECH
  • 12.1.1. Company Overview
  • 12.1.2. Financial Performance
  • 12.1.3. Product Benchmarking
  • 12.1.4. Recent Development
• 12.2. Antech Diagnostics, Inc.
  • 12.2.1. Company Overview
  • 12.2.2. Financial Performance
  • 12.2.3. Product Benchmarking
  • 12.2.4. Recent Development
• 12.3. Avacta Animal Health Limited
  • 12.3.1. Company Overview
  • 12.3.2. Financial Performance
  • 12.3.3. Product Benchmarking
  • 12.3.4. Recent Development
• 12.4. Heska Corporation
  • 12.4.1. Company Overview
  • 12.4.2. Financial Performance
  • 12.4.3. Product Benchmarking
  • 12.4.4. Recent Development
• 12.5. IDEXX Laboratories, Inc.
  • 12.5.1. Company Overview
  • 12.5.2. Financial Performance
  • 12.5.3. Product Benchmarking
  • 12.5.4. Recent Development
• 12.6. Life Diagnostics
  • 12.6.1. Company Overview
  • 12.6.2. Financial Performance
  • 12.6.3. Pro